Competing risks analysis of microsatellite instability as a prognostic factor in colorectal cancer. BJS 2017; 104: 1250-1259.
Published: 12th April 2017
Authors: J. Toh, P. H. Chapuis, L. Bokey, C. Chan, K. J. Spring, O. F. Dent et al.
Despite an extensive literature suggesting that high microsatellite instability (
A hospital database of patients following colorectal cancer resection was interrogated for clinical, operative, pathology, adjuvant therapy and follow‐up information.
Among 1009 patients who had a resection between August 2002 and December 2008, and were followed to at least December 2013, there were 114 (11·3 per cent) with
Microsatellite instability status was not an independent prognostic variable in these patients.Read more
You may also be interested in
Authors: M.E. Kelly, R. Glynn, A.G.J. Aalbers, M. Abraham‐Nordling, W. Alberda, A. Antoniou et al.
Notes: Complete resection is key
Randomized clinical trial
Randomized clinical trial of intracutaneously versus transcutaneously sutured ileostomy to prevent stoma‐related complications (ISI trial).
Authors: M. F. Sier, D. D. Wisselink, D. T. Ubbink, R. J. Oostenbroek, G. J. Veldink, B. Lamme et al.
Notes: More leaks with intracutaneous
Authors: S. J. Chapman, A. Pericleous, C. Downey, D. G. Jayne
Notes: No easy answers.
Randomized clinical trial
Authors: E. M. de Leede, N. J. van Leersum, H. M. Kroon, V. van Weel, J. R. M. van der Sijp, B. A. Bonsing et al.
Notes: Chewing gum no effect on recovery
Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases. BJS 2018; 105: e204-e211.
Authors: I. Ubink, W. J. van Eden, P. Snaebjornsson, N. F. M. Kok, J. van Kuik, W. M. U. van Grevenstein et al.
Notes: Mesenchymal subtype predominates
Authors: E. J. Ryan, E. M. Creagh
Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer. BJS 2018; 105: e192-e203.
Authors: F. C. Koyama, C. M. Lopes Ramos, F. Ledesma, V. A. F. Alves, J. M. Fernandes, B. B. Vailati et al.
Notes: Molecular enhancement of treatment
Clinicopathological, genomic and immunological factors in colorectal cancer prognosis. BJS 2018; 105: e99-e109.
Authors: K. M. Marks, N. P. West, E. Morris, P. Quirke
Notes: Defines modern practice
Gut microbiome influences on anastomotic leak and recurrence rates following colorectal cancer surgery. BJS 2018; 105: e131-e141.
Authors: S. Gaines, C. Shao, N. Hyman, J. C. Alverdy
Notes: A neglected frontier
Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer. BJS 2018; 105: e110-e120.
Authors: O. Nordgård, K. Tjensvoll, B. Gilje, K. Søreide
Notes: The inner space frontier
Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases. BJS 2018; 105: 295-301.
Authors: H. Grut, S. Solberg, T. Seierstad, M. E. Revheim, T. S. Egge, S. G. Larsen et al.
Notes: Immunosuppression may not accelerate growth
Preliminary results of a cohort study of induction chemotherapy‐based treatment for locally recurrent rectal cancer. BJS 2018; 105: 447-452.
Authors: D. M. G. I. van Zoggel, S. J. Bosman, M. Kusters, G. A. P. Nieuwenhuijzen, J. S. Cnossen, G. J. Creemers et al.
Notes: Promising responses